Loading…
Veru Inc. is projected to decline to $2.18 by 2027, a -4% move from its current price of $2.26. VERU is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $2.18 | $2.26 | $2.34 | +0.07% |
| Aug 6 | $2.15 | $2.26 | $2.38 | +0.13% |
| Aug 7 | $2.13 | $2.26 | $2.41 | +0.20% |
| Aug 8 | $2.11 | $2.27 | $2.43 | +0.27% |
| Aug 9 | $2.09 | $2.27 | $2.45 | +0.34% |
| Aug 10 | $2.08 | $2.27 | $2.47 | +0.40% |
| Aug 11 | $2.07 | $2.27 | $2.49 | +0.47% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.07 | $2.27 | $2.49 | +0.47% |
| Week 2 | $2.00 | $2.28 | $2.60 | +0.94% |
| Week 3 | $1.95 | $2.29 | $2.70 | +1.41% |
| Week 4 | $1.91 | $2.30 | $2.78 | +1.89% |
| Week 5 | $1.88 | $2.31 | $2.85 | +2.37% |
| Week 6 | $1.85 | $2.32 | $2.92 | +2.85% |
| Week 7 | $1.82 | $2.34 | $2.99 | +3.33% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Veru Inc. is a late clinical stage biopharmaceutical company focused on developing medicines for metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.
The company develops enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017.
Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Veru Inc. (VERU) is a healthcare stock with a current price of $2.25 and a market capitalization of $36.11M. It holds a position in the market with a rank of 4468. The near- and long-term price outlook is informed by a detailed year-by-year forecast, showing limited upside in the near term but meaningful gains over the longer horizon, including a path to higher averages and sizable potential maximums by 2050.
In 2026 the average forecast is $2.25, with a $2.09-$3.05 range and 0% ROI, and the trajectory progresses to bullish territory by the end of the forecast, with 2050 averaging $8.16 and a max of $18.07, implying substantial cumulative upside over time.
A major floor 29.8% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.2% away) — a key level to hold.
The nearest ceiling, 39.8% above — a clean break opens room to run.
A major ceiling 87.2% above — clearing it would confirm fresh momentum.
Key VERU support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VERU market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.24 | Buy | $2.24 | Buy |
| MA 10 | $2.26 | Sell | $2.29 | Sell |
| MA 20 | $2.43 | Sell | $2.42 | Sell |
| MA 50 | $2.68 | Sell | $2.55 | Sell |
| MA 100 | $2.50 | Sell | $2.58 | Sell |
| MA 200 | $2.58 | Sell | $2.93 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.77 | Neutral |
| Stoch RSI (14) | 61.02 | Neutral |
| CCI (20) | -65.84 | Neutral |
| Williams %R (14) | -85.71 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -7.44 | Sell |
| Bollinger %B (20,2) | 0.29 | Neutral |
| Stochastic %K (14) | 14.29 | Buy |
| TRIX (15) | -0.79 | Sell |
| Awesome (5,34) | -0.45 | Sell |
| Ultimate (7,14,28) | 40.30 | Neutral |
| Momentum (10) | -0.14 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 2.21 | Buy |
| ADX (14) | 19.10 | Neutral |
| ATR (14) | 0.08 | Info |
The near-term technical picture is NEUTRAL. The RSI(14) is 40 and the 50-day simple moving average is $2.67, just above the 200-day moving average of $2.63, which can indicate modest momentum.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.09 | $2.26 | $2.97 | 0% | Neutral | |
| $1.69 | $2.18 | $2.99 | -4% | Neutral | |
| $1.59 | $2.13 | $3.06 | -6% | Neutral | |
| $1.96 | $2.71 | $4.04 | +20% | Neutral | |
| $2.14 | $3.04 | $4.68 | +34% | Bullish | |
| $2.07 | $3.02 | $4.77 | +34% | Bullish | |
| $1.90 | $2.83 | $4.58 | +25% | Bullish | |
| $1.84 | $2.81 | $4.65 | +25% | Bullish | |
| $1.97 | $3.08 | $5.19 | +36% | Bullish | |
| $2.15 | $3.42 | $5.87 | +52% | Bullish | |
| $2.23 | $3.91 | $7.22 | +73% | Bullish | |
| $3.84 | $8.01 | $16.43 | +254% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.09 | $2.26 | $2.69 | +0.00% |
| September 2026 | $1.95 | $2.32 | $2.86 | +2.70% |
| October 2026 | $2.00 | $2.40 | $3.00 | +3.49% |
| November 2026 | $1.93 | $2.34 | $2.96 | -2.40% |
| December 2026 | $1.91 | $2.33 | $2.97 | -0.82% |
Click any year to see its month-by-month VERU forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The VERU price prediction for 2026 points to an average of $2.26 (low $2.09, high $2.97) — a potential gain of 0% on today's $2.26. A consolidation phase looks the most probable path here.
In 2027, VERU is projected to trade between $1.69 and $2.99, averaging $2.18 — a potential decline of -4% from today's $2.26. That is -4% versus the projected 2026 average. Price action looks broadly range-bound.
Veru Inc.'s 2028 outlook centres on $2.13, within a $1.59 to $3.06 range. That is -2% versus the projected 2027 average. That marks a -6% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, VERU could reach as high as $4.04, with a base case around $2.71 and support toward $1.96 — roughly +20% from $2.26. Price action looks broadly range-bound.
Expect VERU to range from $2.14 to $4.68 through 2030. The $3.04 average target implies a +34% move from current prices. That is up +12% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The VERU price prediction for 2031 points to an average of $3.02 (low $2.07, high $4.77) — a potential gain of +34% on today's $2.26. Momentum favours further upside here.
In 2032, VERU is projected to trade between $1.90 and $4.58, averaging $2.83 — a potential gain of +25% from today's $2.26. That is -6% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
Veru Inc.'s 2033 outlook centres on $2.81, within a $1.84 to $4.65 range. That is -1% versus the projected 2032 average. That marks a +25% change versus current levels. Momentum favours further upside here.
By 2034, VERU could reach as high as $5.19, with a base case around $3.08 and support toward $1.97 — roughly +36% from $2.26. Buyers look set to stay in control over this stretch.
Expect VERU to range from $2.15 to $5.87 through 2035. The $3.42 average target implies a +52% move from current prices. That is up +11% on the projected 2034 average. Momentum favours further upside here.
The VERU price prediction for 2040 points to an average of $3.91 (low $2.23, high $7.22) — a potential gain of +73% on today's $2.26. Buyers look set to stay in control over this stretch.
In 2050, VERU is projected to trade between $3.84 and $16.43, averaging $8.01 — a potential gain of +254% from today's $2.26. That is up +105% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in VERU today (≈ 442.477876 VERU) could be worth
$3,543.12
+$2,543.12 (+254%) by 2050 · US Dollar
Based on the average projected VERU price of $8.01 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VERUwould be worth at today's price.
$1,000 invested in VERU on Jul 31, 2025 (≈ 208.333325 VERU) would be worth
$470.83
-$529.17 (-52.9%) today · 0.47× · US Dollar
Based on a VERU entry price of $4.8 vs. today's $2.26.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.25 | $1,004.44 | +0.4% |
| 1 month ago | $3.16 | $715.19 | -28.5% |
| 3 months ago | $2.26 | $1,000 | +0.0% |
| 6 months ago | $2.57 | $879.38 | -12.1% |
| 1 year ago | $4.8 | $470.83 | -52.9% |
| All time (5.0y) ago | $71.2 | $31.74 | -96.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VERU forecast.
Our base-case forecast reaches $4.50 around 2050.
Implied market cap at $4.50: $72.23M
The multi-year forecast shows a mixed to bullish path. In 2026 the avg is $2.25 with neutral sentiment; 2027 avg $2.13 and 2028 avg $2.02, with negative ROIs of -5.3% and -10.1% respectively. The outlook improves in 2029 to an avg of $2.80 (ROI 24.4%), and 2030 to $3.10 (ROI 37.8%).
Through 2031-2035 the avg prices range from $2.98 to $3.50 with ROIs from 23% to 55.5%, and the path remains bullish into 2040 (avg $3.81, ROI 69.1%). The long horizon remains notably bullish with 2050 avg $8.16 and max $18.07 (ROI 262.6%). These figures reflect a long-run upside potential but include years with negative or modest returns and are not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $3.10 with a minimum of $2.09 and a maximum of $4.99, and a predicted ROI of 37.8%. The sentiment is BULLISH.
The yearly forecasts show mixed near-term results, including negative ROIs in 2027 (-5.3%) and 2028 (-10.1%), but a long-run bullish path with 2030 (ROI 37.8%), 2035 (ROI 55.5%), and 2050 (ROI 262.6%). These are estimates, not guarantees.
Yes, the forecast includes a 2034 max of $5.35 and a 2035 max of $6.35, indicating potential upside beyond $5 in those years.
Current price is $2.25 and market cap is $36.11M.
The 30-day range is $1.71 to $2.96, RSI(14) is 40, SMA50 is $2.67, SMA200 is $2.63, with support at $2.26 and resistance at $3.26; sentiment is NEUTRAL and annualized volatility is 80%.
Veru Inc. Community Discussion
0Share your Veru Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.